Rimgaile Urbaityte

发表论文 20 篇 · 总被引 364 次 · h-index 8

代表论文

• Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials (2019 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 216)
• Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials (2018 · Open Forum Infectious Diseases · 被引 42)
• Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA ‐B*5701 Screening as a Risk‐Mitigation Measure (2018 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 被引 23)
• Brief Report: Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis (2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 19)
• Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study (2024 · AIDS and Behavior · 被引 17)
• Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies (2020 · Journal of Infection and Public Health · 被引 16)